pre-update Archives

On-Demand Webinar

Quantitative Systems Pharmacology (QSP) Model Applications in Inflammatory Bowel Disease (IBD) and Alzheimer’s Disease

Meet the Quantitative Systems Pharmacology (QSP) experts and view applications in Inflammatory Bowel Disease (IBD)…

CertaraJune 29, 2023

On-Demand Webinar

Project Optimus: Transforming oncology drug development

CertaraJune 29, 2023

Publication

Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome

Madin–Darby canine kidney (MDCK) cells are widely used to study epithelial cell functionality. Their low…

CertaraJune 28, 2023

Poster

The Usefulness of Combining Clinical Therapeutic Drug Monitoring Data with Bottom-up System Data to Understand the Effect of Renal Impairment on the Non-renal Clearance of Drugs: Tacrolimus as a Drug Example

CertaraJune 28, 2023

On-Demand Webinar

Applying Technology to Expedite Regulatory Writing

Many medical writing capabilities and approaches have matured over the past several years opening the…

CertaraJune 25, 2023

On-Demand Webinar

GlobalSubmit Review and You: How to Expedite the Submission Review Process

Have you ever wondered how you could speed up the submission review process without compromising…

CertaraJune 25, 2023

Announcement

DIDB^® – The Drug Interaction Database, is now part of Certara

PRINCETON, N.J.— June 20, 2023 — Certara, Inc. (Nasdaq: CERT), today announced it has acquired…

CertaraJune 21, 2023

Announcement

Certara Appoints new Chief Marketing Officer, Sheila Rocchio

Princeton, N.J., June 13, 2023 – Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today…

CertaraJune 14, 2023

On-Demand Webinar

What’s New for SEND 2023

This webinar will focus on several changes to the CDISC SEND standard that became active…

CertaraJune 12, 2023

Announcement

Certara Launches Version 8.4 of Phoenix™ Biosimulation Software for Drug Development

Latest updates demonstrate commitment to customers and market leadership of Phoenix Platform PRINCETON, N.J.— June…

CertaraJune 12, 2023

pre-update

Quantitative Systems Pharmacology (QSP) Model Applications in Inflammatory Bowel Disease (IBD) and Alzheimer’s Disease

Project Optimus: Transforming oncology drug development

Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome

The Usefulness of Combining Clinical Therapeutic Drug Monitoring Data with Bottom-up System Data to Understand the Effect of Renal Impairment on the Non-renal Clearance of Drugs: Tacrolimus as a Drug Example

Applying Technology to Expedite Regulatory Writing

GlobalSubmit Review and You: How to Expedite the Submission Review Process

DIDB^® – The Drug Interaction Database, is now part of Certara

Certara Appoints new Chief Marketing Officer, Sheila Rocchio

What’s New for SEND 2023

Certara Launches Version 8.4 of Phoenix™ Biosimulation Software for Drug Development

Newsletter sign up

Quick links

Solutions

Contact